Max Planck Institute of Immunobiology and Epigenetics

Max­Planck­Research Magazine

Issue 2016

MaxPlanckResearch 3/2016

Liaison in a Test Tube
In the mid-1970s, Georges Köhler, later Director at the Max Planck Institute of Immunobiology in Freiburg, succeeded in fusing together a short-lived immune cell and a rapidly dividing cancer cell. The result was an immortal cell chimera with the ability to produce identical (“monoclonal”) antibodies, ushering in a revolution in biology and medical science. In 1984, Köhler was awarded the Nobel Prize along with César Milstein and Niels Kaj Jerne. The researcher, who died young, would have celebrated his 70th birthday this year.
Issue 2012

MaxPlanckResearch 3/2012

Freedom Creates Knowledge
Knowledge changes constantly as research probes the validity of existing knowledge and converts ignorance into new knowledge. Research may also create new ignorance by discovering entirely novel territories whose very existence we had not imagined. Our author analyzes the conditions most conducive to drawing back the curtains.
Issue 2011

MPR 2 /2011

Operating the Genome Switches
Research into epigenetics is a rapidly growing field. A recent conference at the Max Planck Institute of Immunobiology in Freiburg shed light on the reasons.
Issue 2008

MPR 3 /2008

Nature's Pattern Makers
British mathematician Alan Turing developed a model for biological pattern formation over 50 years ago. Turing’s model can be used to explain, for example, how zebras and leopards get their characteristic markings. Scientists at the Max Planck Institute for Immunobiology and their colleagues from the University of Freiburg also discovered how hairy the mathematics behind this phenomenon can be. However, they succeeded in confirming Turing’s model empirically for the first time, and in identifying the key molecular factors that control the characteristic density and distribution of hair on the surface of animal bodies.
Go to Editor View